logo
Login

COHANCE LIFESCIENCES LTD (COHANCE) financials — quarterly results, P&L, cash flow, balance sheet, shareholding

Cohance Lifesciences is a Hyderabad-based CDMO operating across pharmaceutical development, manufacturing, APIs, formulations and specialty chemicals. The company states that it features among the Top 20 CDMOs globally; its Pharma CDMO business works with 19 of the top 20 global innovators, while t…

COHANCEUpdated 29 Aug 2026, 2:29

Cohance Lifesciences Ltd

Market Cap

₹17,215Cr.

Current Price

₹450

High / Low

₹1,039/267

Stock P/E

90.0

ROE5.70%
ROCE7.91%
Book Value₹117
Face Value₹1.00
Dividend Yield0.00%

About

Cohance Lifesciences is a Hyderabad-based CDMO operating across pharmaceutical development, manufacturing, APIs, formulations and specialty chemicals. The company states that it features among the Top 20 CDMOs globally; its Pharma CDMO business works with 19 of the top 20 global innovators, while the API portfolio ranks among the top three suppliers in 8 of its top 10 molecules.[1][2]

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Jun 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios
CategoryMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days1425137653046106115
Inventory Days556278243259284268205302
Days Payable190113100976149117145
Cash Conversion Cycle509217180228253265195272
Working Capital Days205645610799108121159
ROCE %—46%39%50%34%21%21%8%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 29 August 2026 at 2:29

Designed & Shipped by Harshit Bansal